Balloon Infusers Market

Global Market Study on Balloon Infusers: Pain Management Application to Offer Lucrative Opportunities to Market Players

Balloon Infusers Market Segmented By Continuous Rate, Variable Rate Balloon Infusers Product in Pain management, Antibiotic Therapy, Antiviral Therapy, Chemotherapy

  • June-2021
  • PMRREP32517
  • 285 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Market Snapshot

Newly released data by Persistence Market Research on balloon infusers industry analysis shows that global demand enjoyed year-on-year (YoY) growth of 7.1% in 2021 with an expected market value of US$ 970 Mn.

Sales of continuous rate balloon infusers are expected to increase from US$ 655 Mn to over US$ 1.5 Bn by 2031, while that of variable rate balloon infusers from US$ 315 Mn in 2021 to close to US$ 700 Mn in 2031.

Find Out More about the Report Coverage

Companies

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Terumo Corporation
  • Nipro Corporation
  • Smiths Medical
  • Avanos Medical, Inc.
  • Ambu A/S
  • Pfm Medical Ag
  • Daiken Medical Co., Ltd.
  • Palex Medical SA
  • Canack Technology Ltd.
  • PROMECON GmbH.
  • Halomedical Systems Ltd.

Key Points Covered in Balloon Infusers Industry Survey:

  • Market Estimates and Forecasts (2016-2031)
  • Key Drivers and Restraints Shaping Market Growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand Share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Balloon infusers and How to Navigate
  • Recommendation on Key Winning Strategies

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Balloon Infuser Sales Analysis from 2016 to 2020 Vs Market Outlook for 2021 to 2031

Market growth in terms of CAGR from 2016 to 2020 for balloon infusers has been observed as 5.8%, wherein, continuous rate balloon infusers held the highest market share of over 1/3.

Growing demand and rise in adoption of balloon infusers, and their broad range of application in different fluid drug delivery systems are key factors driving market growth.

Moreover, postoperative pain in medical procedures such as total knee pain replacement and total hip replacement is generally treated by infusion of analgesics through balloon infuser pumps. As per a report published by the American Academy in 2018, around 1 million patients and over 1.4 million knee and hip arthroplasty surgeries and procedures were entered into the American Joint Replacement Registry.

Rise in prevalence of chronic diseases, increase in demand for small disposable ambulatory balloon infusers, increasing orthopaedic procedures & surgeries, and technological developments in novel balloon infusers represent major factors boosting market development.

Considering these statistics and shift in dynamics, over the forecast period of 2021-2031, the market is expected to expand at close to 9% CAGR.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

What are the Opportunities on Offer for Manufacturers of Balloon Infusers?

Balloon Infusers can be utilized in portable regional anaesthesia. Various studies also indicate that their usage after shoulder surgery allows early and safe discharge of patients with less need for analgesia. In addition, usage of these pumps in portable regional anaesthesia is rising in cancer care centers, dental care units, and ambulatory care centers in the U.S., which is projected to create significant growth opportunities for key players.

Growing adoption of infusion pumps for delivery of chemotherapy drugs in home care setting and ambulatory care centers is also projected to offer significant opportunities to market players. Usage of these pumps helps in decreasing the wastage of chemotherapy drugs, which helps in reducing the cost of treatment.

Explore Persistence Market Research’s expertise in promulgation of the business !

What is the Main Restraining Factor for Balloon Infuser Suppliers?

High and fluctuating cost of balloon infusers is a major factor hindering demand for these products. For example, cost of infusers delivering antibiotics is extremely low, while cost of infusers delivering pain management drugs is significantly high.

Moreover, stringent regulations related to the use of plastic in balloon infusers are also projected to hinder market growth. For example, the U.S. FDA and the European Commission published a safety evaluation of medical devices containing plasticized polyvinylchloride (PVC) and Di (2-Ethylhexyl) phthalate (DEHP) in parts of balloon infusers.

Therefore, producers require to concentrate on appropriate safety labelling of products to prevent serious side-effects, particularly in the neonatal patient population.

Which Factors are Shaping the Market for Balloon Infusers?

Rising number of medical procedures at hospitals owing to increasing number of accidents and chronic disorders is expected to create opportunities for market growth.

As per the National Cancer Institute, new cases of cancer are assessed to increase up to 23.6 million in the U.S. by 2030. This would need effective drug delivery devices during chemotherapy. Moreover, growing research & development activities are leading to rising production of balloon infusers that are suitable for wide applications, which is augmenting market expansion.

Moreover, balloon infusers are available with some advantageous features such as disposable, lightweight, small size, and eliminate programming errors. Also, they have fewer adverse effects than electronic pumps and are less costly.

Such advantages of balloon infusers over traditional electric infusion pumps are anticipated to create lucrative opportunities for market players over the coming years.

balloon-infusers-market

Country-wise Analysis

What Makes the U.S. the Largest Market for Balloon Infusers?

The market size of the U.S. is estimated to be US$ 286.7 Mn in 2021, backed by increase in the number of chronic diseases in the last few years. At present, the U.S. holds the highest share in the global market, and is relied upon to follow a similar trend during the forecast years.

Rising occurrence of chronic diseases is projected to boost market development in future. Additionally, increasing research & development for novel uses of balloon infusers are anticipated to boost market development.

For example, specialists from the University Hospital of Lausanne, Switzerland, evaluated the utilization of two sub-muscular catheters attached with two balloon infusers in post-operative continuous injury, in September 2018.

Why is Demand for Balloon Infusers Flourishing in the U.K.?

The U.K. market was valued at US$ 38.2 Mn in 2020, and is expected to experience lucrative growth during the forecast period. Increasing geriatric population is the primary factor for the development of the market.

Many people in the country suffer from acute bacterial and viral infections, and require continuous administration of antibiotics. A significant proportion of the geriatric population prefer administering of antibiotics or anti-viral drugs at home care setting over hospital settings. This is boosting demand for balloon infusers in the U.K.

What is Influencing Demand for Balloon Infusers in Germany?

Germany holds a significant share of more than 27% in the European market for balloon infusers, and will exhibit growth of 9.6% during the forecasted period. This is due to high preference of balloon infusers in ambulatory settings, which adds up to annual cost savings due to less equipment cost. Further patient preference for this system is high due to lighter weight, discreetness, and being convenient to use.

How Fast is the Market for Balloon Infusers Growing in India?

The market in India is expected to experience lucrative growth of more than 10% CAGR over the forecast period, mainly due to high incidence of cancer cases in India.

Most chemotherapy drugs are being administered with ambulatory infusion pumps and balloon infusers. Balloon infusers are a better choice over electronic pumps because they require lesser time to prepare and less maintenance cost, which adds up to reduction in time and resources.

What Makes China an Emerging Market for Balloon Infusers?

China dominates the East Asia market with a 78.9% share, and is expected to rise at a CAGR of 10.5% through 2031. In China, demand for balloon infusers has gained traction due to preferred usage in post-operative analgesics infusion in recent years.

Availability of well-developed manufacturing infrastructure, low-cost labor, and trained technicians in the country are supporting growth of the market.

Category-wise Insights

Why is Demand for Continuous Rate Elastomeric Infusion Pumps High?

Continuous rate elastomeric infusion pumps account for substantial share of over 1/3, owing to their broadening applications and growing adoption.

Continuous balloon infusers aid in the maintenance of therapeutic level of medications while treatment is going on, and are preferably used in several chemotherapy infusions. Increasing prevalence of cancer, globally, is expected to drive demand over the forecast period.

Will the Pain Management Application of Balloon Infusers Remain the Most Sought-After?

Pain management application holds a significant revenue share of 44% due to rising number of surgical procedures such as total knee replacement and total hip replacement.

There has been rapid growth in the number of orthopaedic surgeries and procedures. A lot of post-operative pain is experienced after these surgeries. Hence, analgesics is utilized as an efficient drug for pain management after a surgery or operation.

Growing use of medications for managing and reducing pain is expected to significantly result in market growth over the forecast period.

How Has COVID-19 Impacted Demand for Balloon Infusers?

In January 2020, the World Health Organization (WHO) declared the COVID-19 pandemic a health emergency. The pandemic has put a large burden on healthcare systems and emergency rooms that were already overworked and understaffed.

Because of the pandemic, demand for infusion pumps surged. With increase in the number of infections globally, hospitals faced the unavailability of infusion pumps that are utilized for nebulization to support patients suffering from COVID-19 infection.

Governments of various countries are focusing on buying infusion pumps in bulk from manufacturers. As demand for these pumps is suddenly increasing, global as well as domestic players are increasing their manufacturing capacities to meet this rising demand. Considerably, the impact of the pandemic on the market was positive and is projected to remain the same in the near future.

Insights into Balloon Infusers Market Competitive Landscape

Key players are focusing on business expansion in emerging countries and introducing features in their product line. Market players are also engaged in expanding their regional presence through acquisitions, collaborations, expansions, product launches, and improvement of distribution channels.

  • In 2019, Terumo Corporation announced the launch of its TERUFUSION Infusion Pump Type LM Series, which utilize smart cutting-edge IT solutions to deliver optimal management and prevents inadvertent excess infusion of drugs into patients.

Scope of Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

  • USD Million for Value
  • Volume (Units)
  • Pricing Analysis

Key Region Covered

  • North America
  • Latin America
  • Europe
  • MEA
  • East Asia
  • South Asia
  • Oceania

Key Countries Covered

  • US
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Benelux
  • Russia
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Australia
  • New Zealand
  • South Africa
  • Turkey
  • GCC Countries

Key Segments Covered

  • Product
  • Application
  • End User
  • Region

Key Companies Profiled

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Terumo Corporation
  • Nipro Corporation
  • Smiths Medical
  • Avanos Medical, Inc.
  • Ambu A/S
  • Pfm Medical Ag
  • Daiken Medical Co., Ltd.
  • Palex Medical SA
  • Canack Technology Ltd.
  • PROMECON GmbH.
  • Halomedical Systems Ltd.

Report Coverage

  • Market Forecasts
  • Company Share Analysis
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Market Segments Covered in Balloon Infusers Industry Research

Product

  • Continuous Rate Balloon Infusers
  • Variable Rate Balloon Infusers

Application

  • Balloon Infusers for Pain Management
  • Balloon Infusers for Antibiotic Therapy
  • Balloon Infusers for Antiviral Therapy
  • Balloon Infusers for Chemotherapy
  • Others

End User

  • Balloon Infusers for Hospitals
  • Balloon Infusers for Ambulatory Surgical Centers
  • Balloon Infusers for Home Care Settings
  • Balloon Infusers for Speciality Clinics
  • Others

Enquiry before Buying

  • Is this research conducted by Persistence Market Research?

    Yes, the research has been conducted by expert analysts of Persistence Market Research, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

  • What research methodology is followed by Persistence Market Research?

    Persistence Market Research follows a methodology that encompasses the demand-side assessment of the market and triangulates the same through supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

  • Who are the respondents for primary research?

    Persistence Market Research speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

  • What are the sources of secondary research?

    Persistence Market Research conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

  • Is a sample of this report available for evaluation?

    Yes, you can request a sample, and it will be sent to you through email.

  • How can I buy this report?

    Persistence Market Research provides a secure online payment system to buy reports seamlessly. You can buy the report securely and safely.

Media Release

- FAQs -

The global balloon infusers market was worth US$ 905.7 Mn in 2020, and is estimated to end up at US$ 970 Mn in 2021.
The market for balloon infusers is expected to top US$ 2.5 Bn in 2031, with continuous elastomeric infusion pumps holding maximum revenue share.
Historically, the balloon infusers industry has grown at a CAGR of 5.8%.
Development of user-friendly advanced disposable pumps, rising competition and increasing local production, growing demand for balloon infusers from homecare services, and technological innovations in infusion pumps are reshape the novel balloon infusers space.
Growing inclination toward treating cancer at home or at long-term palliative care centers is boosting demand for balloon infusers to be used in chemotherapy.
Cumulative market share of the top 5 players constitutes around 45% of the overall market.
The U.S., U.K., Germany, China, and India are the top 5 countries driving most of the demand for balloon infusers.
North America holds around 1/3 revenue share in the overall balloon infusers market. Canada holds around 3.6% of the global market share.
The European market is set to exhibit a CAGR of 8.2% over the forecast period, owing to increasing geriatric population, rising healthcare expenditure, and increasing government initiatives toward healthcare.
The U.S., Germany, China, and Japan are key countries involved in the manufacturing of balloon infusers.
After China, Japan is the next leading country in the East Asia market, and is expected to hold a share of 4.1% by 2031 in the global market. Though South Korea holds less revenue share, it is expected to expand at a CAGR of 9.4%.
The global balloon infusers market was worth US$ 905.7 Mn in 2020, and is estimated to end up at US$ 970 Mn in 2021.
The market for balloon infusers is expected to top US$ 2.5 Bn in 2031, with continuous elastomeric infusion pumps holding maximum revenue share.
Historically, the balloon infusers industry has grown at a CAGR of 5.8%.
Development of user-friendly advanced disposable pumps, rising competition and increasing local production, growing demand for balloon infusers from homecare services, and technological innovations in infusion pumps are reshape the novel balloon infusers space.
Growing inclination toward treating cancer at home or at long-term palliative care centers is boosting demand for balloon infusers to be used in chemotherapy.
Cumulative market share of the top 5 players constitutes around 45% of the overall market.
The U.S., U.K., Germany, China, and India are the top 5 countries driving most of the demand for balloon infusers.
North America holds around 1/3 revenue share in the overall balloon infusers market. Canada holds around 3.6% of the global market share.
The European market is set to exhibit a CAGR of 8.2% over the forecast period, owing to increasing geriatric population, rising healthcare expenditure, and increasing government initiatives toward healthcare.
The U.S., Germany, China, and Japan are key countries involved in the manufacturing of balloon infusers.
After China, Japan is the next leading country in the East Asia market, and is expected to hold a share of 4.1% by 2031 in the global market. Though South Korea holds less revenue share, it is expected to expand at a CAGR of 9.4%.

Recommendations

Telemedicine Market

Global telemedicine market slated for over 17% CAGR in terms of revenues, over 2019-2029. .

UK Private Healthcare Market

Global private healthcare market to grow from more than US$ 11,600 mn in 2016 to over US$ 14,000 mn by 2025 end. This represents a CAGR of 2.8% over the forecast period.

Medical Case Management Services Market

Global medical case management services market is predicted to clock a CAGR of 3.04% along with a healthy revenue for the forecast period between 2017-2021.

Medical Wellness Market

Global medical wellness market was valued at over US$ 1 Tn in 2020, and is expected to exhibit a CAGR of 14.1% over the forecast period (2021-2031).

Our Clients

Our Clients